Xencor (NASDAQ:XNCR – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.37) EPS for the quarter, topping the consensus estimate of ($0.91) by $0.54, Briefing.com reports. The firm had revenue of $45.52 million during the quarter, compared to analyst estimates of $26.25 million. Xencor had a negative return on […]
Related Keywords
United States , Hong Kong , America , Bassili Dahiyat , , Sei Investments Co , Hong Kong Ltd , Lazard Asset Management , Securities Exchange Commission , Xencor Company Profile , Xencor Inc , Tower Research Capital , Get Free Report , Exchange Commission , Research Capital , Asset Management , Kong Ltd , Sei Investments , Xencor Daily , Xencor , Nasdaq Xncr , Xncr , Medical , Earnings ,
comparemela.com © 2020. All Rights Reserved.